Skip to main content

Home/ MaRS/ Group items tagged sustainability

Rss Feed Group items tagged

Assunta Krehl

The 2010 Annual International Conference on Research Facilities - PRNewswire - March 2,... - 0 views

  •  
    On May 17 & 18 the 2010 Annual International Conference on Research Facilities will be held in Toronto. The major issues on the agenda include getting more research results per square foot of space, lowering the costs of building and renovating research facilities, reducing facility operating costs, facilitating the new collaborative multi-disciplinary research models, planning facilities help to promote commercial technology spin-offs, and designing energy-efficient and sustainable laboratories.An important feature of the conference is the opportunity for participants to tour a number of prominent Toronto research facilities including MaRS Discovery District.
Assunta Krehl

Samsung and the Economy - The Agenda - February 2, 2010 - 0 views

  •  
    Watch MaRS cleantech advisor and practice lead, Tom Rand, as he appears on a panel on TVO's The Agenda with Steve Paikin. The issue: the Samsung deal - good for Ontarians or not? Other panelists on the Feb 2, 2010, show include: Randall Denley from the Ottawa Citizen; Kristopher Stevens from the Ontario Sustainable Energy Association; and Norm Rubin from Energy Probe.
  •  
    With Steve Pakin host of The Agenda, Norm Rubin, Director of Nuclear Research, Randall Denley, Columnist with the Ottawa Citizen, Tom Rand, Cleantech Lead at the MaRS Discovery District, and Kristopher Stevens, Executive Director of the Ontario Sustainable Energy Association discuss the harnessing nature to boost Ontario's economy--what the Samsung deal means for Ontario.
Tim T

United States: Square-root reversal | The Economist - 0 views

  • America will recover, but too weakly for comfort
  • a cycle that resembles not a V, U or W, but a reverse-square-root symbol: an expansion that begins surprisingly briskly, then gives way to a long period of weak growth.
  • Based on experience, the American economy, which shrank by some 4% over the course of the 2007-09 recession, ought to grow by as much as 8% in its first year of recovery. The unemployment rate, around 10% in late 2009, should drop to about 8%.
  • ...5 more annotations...
  • That won’t happen.
  • None of these factors, however, can sustain strong growth past 2010 without a self-sustaining cycle of private spending and income growth. Several obstacles stand in the way of that transition. Through to mid-2009 households had lost $12 trillion, or 19% of their wealth, because of the collapse in house and stock prices. That saps their purchasing power and pushes them to save more, especially those nearing retirement. Though they’ll boost their saving only gradually, that still means consumer spending (about 70% of GDP) will grow more slowly than income, after two decades in which it usually grew more quickly. High unemployment will hold back wage gains (see chart); wage cuts are already commonplace. Leaving aside swings in energy prices, inflation, now about 1.5%, will slip to zero and may turn to deflation in late 2010. Deflation drives up real debt burdens, further sapping consumer spending.
  • The government won’t let any more big banks fail, but the survivors are neither inclined nor able to expand their lending much. Residential- and commercial-property values fell by $8 trillion, or almost 20%, through to mid-2009, impairing existing loans and eroding the collateral for new ones. Regulators are also proposing to raise capital requirements, which will further encourage bankers to turn down borrowers.
  • the rest of the world isn’t big or healthy enough, and a steeply falling dollar would inflict deflationary harm on others.
  • The list of roadblocks is depressing, but America will not slip back into recession or a lost decade akin to Japan’s in the 1990s. It did not enter its crisis with as much overinvestment as others, Japan in particular; its population is still growing (Japan’s is shrinking). It took two years to tackle its banks’ problems; Japan took seven. Boom times will be back. Just not very soon.
Assunta Krehl

Opinion: Would you pay a trillion bucks to save the Earth? - Canadian Business Magazine... - 0 views

  •  
    Tom Rand, Cleantech Lead at MaRS, and author of Kick the Fossil Fuel Habit: 10 Clean Technologies to Save Our World says "it will take a massive investment to kick our fossil fuel addiction. Clean energy can be the basis of sustained economic prosperity over the next few decades. But only if we decide to do it."
Assunta Krehl

Green elites meet the people - National Post - May 29, 2010 - 0 views

  •  
    E(3) Canadian Roundtables took place May 26, 2010. The event featured a panel of thought leaders sharing their vision for a sustainable energy future for Canada. Tom Rand, Cleantech Advisor at the MaRS Discovery District spoke at the event.
Assunta Krehl

Sustainable Toronto - Future 360 - October 17, 2011 - 0 views

  •  
    Sarah Backhouse, host of Future 360, states Toronto is the centre of cleantech. Backhouse interviews Jon Dogterom and Tom Rand, MaRS Senior Cleantech Advisors. MaRS Discovery District assist entrepreneurs in accelerating the commercialization and the creation of new jobs in the cleantech field.
Assunta Krehl

Idea dearth at big money sustainability summit - Environment Forum - November 2, 2011 - 0 views

  •  
    Tom Rand, MaRS Senior Cleantech Advisor attended the United Nations Environment Program Finance Initiative (UNEP FI) and blogs his take on the outcome of the summit.
Assunta Krehl

Building on Rio + 20: Canada's role and priorities in a global green economy -CPCA - Ma... - 0 views

  •  
    Th 20th anniversary of the Rio Earth Summit to place in Ottawa and was intended to chart a course for global sustainable development. Jon Dogterom, MaRS Discovery District Lead Advisor, Cleantech was a member on the panel that discusses how canada was performing in "greening the economy."
Cathy Bogaart

Why a social mission can be good for business - The Globe and Mail - 1 views

  •  
    Allyson Hewitt, the lead of our social innovation practice at MaRS, talks live at the G&M about why businesses should consider having a social mission.
Cathy Bogaart

Leading Toronto into sustainability: a Q & A with cleantech guru Tom Rand - Yonge Stree... - 1 views

  •  
    MaRS lead cleantech advisor, Tom Rand, talks to Yonge Street magazine about the cleantech market, what Toronto's doing right and where the opportunities are to do better.
Assunta Krehl

Test-tube industry - Canadian Business - 0 views

  • For Dr. John Evans, growing a strong biotechnology industry is much the same: cities must provide a nurturing environment where science and business can thrive together.
  • That's why Evans, former president of the University of Toronto and current chairman of Torstar Corp., is spearheading the $345-million Medical and Related Science initiative, or MaRS--a petri dish of sorts for commercializing science research. "A lot of intellectual property is being commercialized outside Canada," says Evans. "I think we've been slow in realizing just how important technology developments are to the economic future of the country. MaRS is an attempt to give this a kick into a higher gear." The centrepiece of the MaRS plan, which will officially launch May 12, is a 1.3-million-square-foot, five-building complex in downtown Toronto that will provide office and lab space for small and medium-size companies and incubators, including the not-for-profit Toronto Biotechnology Commercialization Centre. While Evans is reluctant to limit its scope, MaRS will generally focus on health-related technologies, from new drugs and genetic treatments to medical devices and imaging software. Branded a "convergence centre," it will also house a careful mix of support services: intellectual property lawyers, accountants, marketing experts, government funding organizations and venture capital financiers. Plus, start-ups will have access to all the latest equipment on site. For instance, MaRS is in talks with MDS Sciex to supply mass spectrometers, used in proteomics research.
  • But MaRS will be more than just a New Economy real estate development. Evans's intention is to funnel tenants' rent money into services--such as entrepreneurship seminars and angel-matching programs--that MaRS will offer to the broader biotech community. That's why MaRS's location is key: the centre will be built in the heart of what Toronto has dubbed the "Discovery District," a two-square-kilometre chunk of the downtown core, encompassing U of T and four major hospitals. From there, MaRS hopes to act as a network hub across Ontario, with links to research-intensive universities. "None of them," says Evans, "have the critical mass to put it all together on their own."
  • ...3 more annotations...
  • MaRS's primary goal is to get Toronto and the rest of Ontario on the global biotech map. Evans came up with the concept in the late 1990s with Dr. Calvin Stiller, CEO of the labor-sponsored Canadian Medical Discoveries Fund, and Kenneth Knox, a former deputy minister for the Ontario government who's now CEO of MaRS
  • As far as schemes to support fledgling industries go, MaRS is refreshing. To start, it's a nonprofit corporation, not a government program, which will hopefully ensure that it runs more efficiently. The feds and the province of Ontario have each doled out $20 million for MaRS, and Toronto has donated in-kind $4.5 million. More than $12 million has come from a small pool of corporations, including Eli Lilly Canada and MDS, as well as individual donors like Joseph Rotman and Lawrence Bloomberg (who both sit on the MaRS board). U of T pitched in $5 million, and MaRS also did some innovative bond financing to round off the $165 million needed to build Phase I. "It was very important for us to not belong to anybody," says Evans.
  • Now MaRS's challenge is to get the word out. Its posted rate of $26 per square foot is very competitive for prime downtown real estate and is sure to attract attention, especially considering its customized lab space. But MaRS's success won't be measured by a low vacancy rate; getting the right mix of scientists, entrepreneurs and professionals is critical if it plans to commercialize some sustainable businesses. It won't happen overnight--in fact, it may be 10 years before anyone can gauge MaRS's impact. Seems growing a biotech industry isn't quite as easy as growing E. coli in a petri dish.
  •  
    John Evans spearheads the MaRS project which will help to accelerate commercialization for scientific research. The official launch of the MaRS plan will happen on May 12, 2003.
Sarah Hickman

Amazon.com: The Innovator's Solution: Creating and Sustaining Successful Growth (978157... - 0 views

  •  
    From Publishers Weekly\nChristensen (The Innovator's Dilemma) analyzes the strategies that allow corporations to successfully grow new businesses and outpace the other players in the marketplace. Christensen's earlier book examined how focusing on profits can destroy even well-run corporations, while this book focuses on companies expanding by being "disruptors" who are able to outpace their entrenched competition. The authors (Christensen is a professor at Harvard Business School and Raynor, a director at Deloitte Research) examine the nine business decisions integral to growth, including product development, organizational structure, financing and key customer base. They cite such companies as IBM, AT&T, Sony, Microsoft and others to illustrate their points. Generally, the writing is clear and specific. For example, in discussing whether a company has the resources necessary for growth, the authors say, "In order to be confident that managers have developed the skills required to succeed at a new assignment, one should examine the sorts of problems they have wrestled with in the past. It is not as important that managers have succeeded with the problem as it is for them to have wrestled with it and developed the skills and intuition for how to meet the challenge successfully the next time around"; they then provide a real-life example of a software company. Similar important strategies give readers insights that they can use in their own workplaces. People looking for quick fixes may find the charts, diagrams and extensive footnotes daunting, but readers familiar with more technical business management tomes will find this one both stimulating and beneficial.
Assunta Krehl

Social masterminds challenging social media for social change | danielpatricio.com - 0 views

  • Netchange Week taking place at the innovation hub of Toronto – the MaRS Discovery District.
  • Net Change is Canada’s first week long, city wide event designed to dissolve the divide between digital professionals and social change-makers. With a full five day schedule of sessions helping learn more about leveraging technology to aid awareness of their causes and as a catalyst for social change.
  • ssues faced by the charity we noticed they shared similar problems that many for-profits and small businesses faced. They had limited marketing resources, need to reach out the people that need their services and increase awareness of the good work they were doing.
  • ...5 more annotations...
  • The challenge we faced was how do we increase awareness
  • We looked at how with a simple web cam or flip camera we could share the strongest messages that people needed to hear.
  • most important social media tools can be email and a blog.
  • tools are important for four reasons. They leverage existing investments of time and resources They allow orgs to add multimedia to existing communication channels eg. newsletters They enable easier sharing than existing tools They are sustainable
  • Social media strategy needs to be adopted by the whole organisation not just by someone who is technically savvy.
  •  
    Daniel Patricio's take on Net Change Week at MaRS. Net Change week is a city wide event designed to reduce the divide between digital professionals and social change-makers.
Assunta Krehl

Room for the Future - 0 views

  • 2009 Cleantech Issue
  • exclusive look at the continent’s greenest hotel: The Planet Traveler Hotel in Kensignton Market, Toronto.
  • The big talk by the cleantech lead at the MaRS Discovery District, and the man behind VCi Greenfunds and Green Bonds, is backed by bigger action. Rand’s latest project is what he claims to be “the continent’s greenest hotel”, which Corporate Knights first told you about in October 2008.
  • ...8 more annotations...
  • Speaking to a full house at Toronto's MaRS Centre on July 9, 2009, Tom Rand explains why he has decided to focus on buildings in his approach to climate change. “Buildings are responsible in our large urban centres for between a half and three quarters of our carbon emissions. That’s a huge part of our footprint,” he says. “In terms of climate change, buildings are the lowest hanging fruit, as far as I can tell.”
  • Tom Rand’s talk Green or Green Wash? Lessons from Building North America’s Greenest Hotel in Toronto
  • According to Tom Rand, if you’re not talking low carbon, you’re greenwashing.
  • Tom Rand believes any building can and should achieve in the immediate future using sustainable technologies that already exist.  Moreover, he claims to have found a magic bullet, alleging that these carbon cuts can be made without spending a dime.
  • and has come a long way since then, transforming the Planet Traveler hostel into a kind of cleantech gallery. Utilizing solar-voltaic and solar-thermal heating, geo-exchange, 100% LED lighting, and a wastewater heat re-capturing unit called the Powerpipe, it boasts a rich collection of renewables. It also seeks to educate. The geo-exchanger and Powerpipe are featured behind a glass wall in the basement, and the rooftop mezzanine bar offers a full view of the solar panels in the foreground of Toronto’s skyline.
  • Rand had to look to an adjacent alley to bury the pipe.
  • Rand, a carbon tax, widespread education campaigns, and third party support for green infrastructure via green bonds or a geo-utility are sure-fire ways “to build a cleantech economy in Canada without spending a dime.”
  • If any country wants to participate in the next economic revolution they had better start dealing with clean-tech and they had better start dealing with it quickly.”
  •  
    An exclusive look at the continent's greenest hotel: The Planet Traveler Hotel in Kensignton Market, Toronto. Tom Rand talks about Cleantech and the lessons he has learned from Building North America's Greenest Hotel in Toronto
  •  
    An exclusive look at the continent's greenest hotel: The Planet Traveler Hotel in Kensignton Market, Toronto. Tom Rand talks about Cleantech and the lessons he has learned from Building North America's Greenest Hotel in Toronto.
Assunta Krehl

Pharmafocus.com - 0 views

  • Canada has always had to fight hard to attract talent and investment
  • MaRS Vital to Toronto's life sciences vision is MaRS (derived from Medical and Related Sciences) a non-profit organisation and business centre located in the heart of the city. Its core function is as a biotech incubator and business park, known as MaRS Discovery District. The venture was first established in 2000 to help foster and accelerate the growth of successful Canadian businesses and, after some uncertain times, it is now gathering momentum. A separate technology transfer office, MaRS Innovation, has also been established that, it is hoped, can be a world beater in its own right (see Turning good ideas into world beaters below). The location of the MaRS building in central Toronto is important, as it is just a stone's throw away from an existing cluster of universities and academic hospitals. MaRS has many links with other research-based organisations, including collaborations with three local universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS occupies the Old Toronto general hospital, where insulin was first discovered by Best and Banting in 1921 and then developed for use in human trials. The 21st Century organisation can build on this heritage in patient-focused discovery and development. Formerly the head of venture capital firm Primaxis, Ilse Treurnicht is chief executive of MaRS Discovery District. She acknowledges the crisis in venture capital funding, and says Canada's sector has always had less access funds through this route than other countries. This is one of the drivers behind the search for a new approach. Treurnicht says the old models of building biotech and life sciences businesses have to be discarded, as they have failed to build companies with critical mass. She says MaRS' new 'Convergence Innovation' strategy of bringing science, capital and business together will pay off.
  • "We call our strategy 'Convergence Innovation' and what we are trying to do is move away from the old linear model of academics struggling in their spare time to build companies or entrepreneurs doing this in a very incremental way."It takes time and it has many risk points along the way. So using this Convergence centre model to create a much more dynamic organisation which can help accelerate good ideas towards the commercialisation." But she says Canada's geography and demographics are always going to be a challenge. "This is a very large country with a small population. If you think in terms of clusters and hub regions, Canada's business hubs are separated geographically, and there is not much in between in terms of people."That means we can't try to be a little United States, because we just won't show up on the radar. We have to take a different approach. We have to think about collaboration as our potential competitive advantage - that means using networks and associations to solve problems and build businesses."So as new opportunities emerge, we can take them to market faster and hopefully with a higher success rate." The centre currently accommodates numerous start up companies, as well as those providing legal and financial services to them. AstraZeneca and GlaxoSmithKline also have offices on site. In all, MaRS provides mentoring for over 200 different companies across Ontario, and runs courses on entrepreneurship and preparing products for market.
  • ...7 more annotations...
  • Transition Therapeutics is one of the companies based at MaRS, and is an example of a biopharmaceutical company that is taking a new approach to the science and business of drug development.
  • Now Toronto's MaRS Innovation (MI) has been launched to try to guide and accelerate these promising ideas out of the wilderness and onto the market. MI is a not-for-profit technology transfer company that will channel all the best ideas to come out of Toronto's renowned academic centres. In the Toronto and Ontario area there were between 14-16 different technology transfer offices in the different institutions, and MaRS Innovation resolved to bring these interests together into a single entity after industry partners told them it was an inefficient way to do business. Bringing together the different institutions under one umbrella organisation has been an arduous task for MaRS, but the reward could be considerable for all parties. MI now oversees probably the largest intellectual property pipeline of its kind, representing about $1 billion in annual research spending. This means MI will be a unified route for all of Toronto's academics and their institutions when they want to develop and commercialise a bright idea. Most importantly, investors from industry who are looking to collaborate will now be able to deal with just organisation and one IP process. MI will cover patentable ideas across a broad range of areas, and not just life sciences - the discovery pipeline in physical sciences, information and communication technology, and green technology ('cleantech') will all be funnelled through MI. MI now represents three universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS Innovation, with support from MaRS and BioDiscovery Toronto, will advance commercialisation through industry partnerships, licensing and company creation.
  • ts chief executive is Dr Rafi Hofstein. Hofstein has been headhunted from Israel where he was chief executive of Hadasit, the technology transfer company of the Hadassah Medical Organization in Jerusalem and chair of the publicly-traded company Hadasit BioHolding. He brings this considerable experience in technology transfer to what he thinks is a groundbreaking enterprise."MaRS Innovation is a unique global initiative, and I must commend the institutional leaders in Toronto for pulling this innovation powerhouse together to strengthen commercialisation output." He adds: "I believe this is going to modernise the whole notion of tech transfer." He says the scale and diversity of MaRS Innovation's remit puts it into a league of its own. Other research clusters elsewhere in the world have attempted similar projects before, but have been thwarted by the difficulty in bringing parties together. MaRS Innovation will also help launch and grow new spin-off companies and incubate them for 2-3 years to ensure a strong commercial footing. Hofstein says MI will also fund proof of concept trials which will persuade major pharma companies to invest in their development.
  • MI has just announced its first two commercialisation deals with academic partners in the city. The first is with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital to develop stem cell from umbilical cords to treat cardiovascular disease, diabetes and neurological disorders. "With the Toronto area identified as a world-leading cluster in stem cell research, we are extremely excited to have identified this technology as our first commercialisation opportunity," said Dr Hofstein.
  • "Our partnership with MaRS Innovation on developing methods for using stem cells for diseases such as diabetes will allow us to work towards advancing care for these critical conditions."
  • The second collaboration is between MI and The University of Toronto (U of T) and involves a novel sustained release formulation of nitric oxide (NO) for applications in wound healing, including diabetic ulcers. "There are 300 million diabetics worldwide, of which some 15% develop troublesome foot ulcers. This wound healing technology is extremely exciting, making it an early commercialisation opportunity that MaRS Innovation has identified as being a potential win for some 45 million diabetics globally," said Dr Hofstein.
  • "This is one of many new commercialisation ventures that will be initiated by MaRS Innovation, our partner in commercialisation of research with 13 other academic institutions across the Greater Toronto Area," said Paul Young, U of T's vice-president, Research. "We at U of T are delighted that this innovation from Dr Lee will be taken to the marketplace to the benefit of society and the economy of Ontario and Canada." By aggregating the leading edge science of its institutional members and being a one-stop commercialisation centre for industry, entrepreneurs and investors, MI could really help put Toronto and Canada on the map."MaRS Innovation is deeply committed to facilitating strategic research collaborations with industry partners, strengthening the innovation capacity of Canadian industry through adoption of new technologies, and launching a new generation of robust, high-growth Canadian companies that will become global market leaders," added Dr Hofstein. "We look forward to working closely with all of our institutional members and to continue to jointly announce exciting commercial opportunities."
  •  
    Canada has always had to fight hard to attract talent and investment. As stated in Pharmafocus.com, "MaRS Discovery District helps to foster and accelerate the growth of successful Canadian businesses." MaRS Innovation has also been launched to accelerate ideas onto the market.
Assunta Krehl

Local - A green leader in her own right - TheRecord.com - 0 views

  • Studio Earth. The youth workshop hosted by Social Innovation Generation -- a working group at the University of Waterloo -- is designed for young people interested in environmental issues.
  • Cullis-Suzuki said she's looking forward to speaking about social innovation. Innovators are badly needed to build a sustainable economy, she said.
  • The social technology workshop will be on using the internet for social purposes. It will be led by Joseph Dee of the MaRS Centre, a Toronto centre for scientific research, and Sam Ladner, a York University sociologist.
  • ...1 more annotation...
  • social and environmental change
  •  
    Cullis-Suzuki talks about social innovation and environmental change and will be talk at Studio Earth. Studio Earth Participants will attend on of three workshops. Mention of Social Technology workshop will be using the internet for social purposes which will be led by Joseph Dee.
  •  
    Cullis-Suzuki talks about social innovation and environmental change and will be talk at Studio Earth. Studio Earth Participants will attend on of three workshops. Joseph Dee will lead the Social Technology workshop - using the internet for social purposes. Jan 9, 2009
Assunta Krehl

Clean Technologies Will Drive Ontario's Future Economic Prosperity - Sustainable Develo... - 0 views

  • Ontario's clean technology industry is poised for growth, and is comprised of companies that manufacture, develop and sell competitive products. Despite this promise, these companies face key challenges in becoming globally competitive - including lack of growth capital, weak domestic demand, and a small pool of management experienced in product commercialization.
  • Ogilvy Renault LLP, MaRS Discovery District, Blake, Cassels & Graydon LLP, Export Development Canada, RBC, Department of Foreign Affairs and International Trade, Ontario BioAuto Council, TMX Group Inc., Canada's Venture Capital & Private Equity Association, National Angel Capital Organization, XPV Capital and Investeco Capital.
  •  
    Ontario's clean technology industry is poised for growth, and is comprised of companies that manufacture, develop and sell competitive products. Cleantech companies need to gain greater globalization and increase their product commercialization.
  •  
    Ontario's clean technology industry is poised for growth, and is comprised of companies that manufacture, develop and sell competitive products. Cleantech companies need to gain greater globalization and increase their product commercialization. Feb 17, 2009
Cathy Bogaart

Entrepreneurs doing good | Saving the world | The Economist - 0 views

  • The temple has a conference room equipped with state-of-the-art audio-visual aids. Its board of directors includes several leading software billionaires and their wives, providing it with money as well as connections.
  • The monks are entrepreneurs as well as holy men, one moment talking about reincarnation and the next about sustainable delivery models.
  • he temple provides 200,000 local schoolchildren with free meals every day.
  • ...3 more annotations...
  • purpose of feeding India’s rural poor. He invested $1m—and many years of his life—in breeding a superchicken
  • invented a “lapdesk” that sits on the child’s lap and provides a stable surface. The desks are covered in advertisements, so Mr Immelman is able to hand them out free,
  • In the long run, however, the best thing that entrepreneurs can do for the poor may be simply to see them as workers and customers.
  •  
    The Economist shows how different entrepreneurs around the world are creating businesses with the goal of improving the world, while still making money: social entreprenuership
Sarah Hickman

Gagglescape, world changing technologies meet social networks, sustainability, and capital - 0 views

  •  
    gagglescape is a forum for Canada's entrepreneurs and venture investors. While they have an information technology bias, gagglescape is a place to find or exchange information on all innovation-driven markets. The site uses social networking tools to help promote entrepreneurship and investment in Canadian knowledge based industries.
‹ Previous 21 - 40 of 46 Next ›
Showing 20 items per page